MARTIN TEICHER, MD, PHD
Martin Teicher, MD, PhD, has been director of the Developmental Biopsychiatry Research Program at McLean Hospital since 1988. He was the director of the former Developmental Psychopharmacology Laboratory (now the Laboratory of Developmental Neuropharmacology) and is currently an associate professor of psychiatry at Harvard Medical School.
Dr. Teicher is a member of the editorial board of the Journal of Child and Adolescent Psychopharmacology, Current Pediatric Reviews, and Current Psychosomatic Medicine. He is a member of the Scientific Advisory Council of the Juvenile Bipolar Research Foundation and has been part of Harvard University’s Brain Development Working Group. He has served on or chaired numerous review committees for the National Institutes of Health, published more than 150 articles, and has received numerous honors.
Speaker Disclosures:
Financial: Dr. Martin Teicher has employment relationships with Harvard Medical School and McLean Hospital. He receives grants from ANS Research Foundation, MIDA, Harvard Brain Science Initiative Bipolar Disorder Seed Grant, NIH/NIDA - National Institute on Drug Abuse. Dr. Teicher receives compensation as a consultant. He receives a speaking honorarium and recording royalties from PESI, Inc. He has no relevant financial relationships with ineligible organizations.
Non-financial: Dr. Martin Teicher serves on the scientific advisory board for SMARTfit™ and is a board member of the National Academy of Sciences, Engineering and Medicine, the Children, Youth and Families of National Academy of Sciences, and the Trauma Research Foundation. He is a trustee of Robert E. Kahn MD and Elizabeth L. Kahn Family Foundation. Dr. Teicher is a member of the International Behavioral Neuroscience Society, the International Society for Traumatic Stress Studies, the Society of Biological Psychiatry, and the American Academy of Child and Adolescent Psychiatry. He is a is an Ad hoc reviewer and editor for several peer review journals, for a complete list contact PESI, Inc.